KAYSEN DAVID B 4
4 · Sun BioPharma, Inc. · Filed Jun 14, 2018
Insider Transaction Report
Form 4
KAYSEN DAVID B
President and CEO
Transactions
- Purchase
Common Stock
2018-05-16+1,000→ 51,000 total - Purchase
Warrant (right to buy)
2018-05-16+1,000→ 1,000 totalExercise: $5.00From: 2018-05-16Exp: 2021-05-16→ Common Stock (1,000 underlying)
Footnotes (1)
- [F1]Reflects purchase of 1,000 units from the issuer at a price equal to $5.00 per unit. Each unit consisted of one share of common stock and a warrant to purchase an additional share of common stock.